Christopher Patusky - Jan 3, 2023 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Jan 3, 2023
Transactions value $
-$370,580
Form type
4
Date filed
1/4/2023, 03:30 PM
Previous filing
Nov 18, 2022
Next filing
Mar 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $176K +2K +119.05% $88.03 3.68K Jan 3, 2023 Direct F1
transaction UTHR Common Stock Disposed to Issuer -$547K -2K -54.35% $273.32 1.68K Jan 3, 2023 Direct F1
holding UTHR Common Stock 1.1K Jan 3, 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 +2K +33.33% $0.00 8K Jan 3, 2023 Common Stock 2K $88.03 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
F2 Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.